Variant report
Variant | nsv523306 |
---|---|
Chromosome Location | chr13:86618098-86628241 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372757729 | chr13:86624864-86624865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536667904 | chr13:86624899-86624900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543543396 | chr13:86624923-86624924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs141770473 | chr13:86625016-86625017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573908014 | chr13:86625040-86625041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75799654 | chr13:86625044-86625045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147085065 | chr13:86625084-86625085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs74102174 | chr13:86625143-86625144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545230069 | chr13:86625165-86625166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372670059 | chr13:86625200-86625201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143912851 | chr13:86625210-86625211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543271111 | chr13:86625278-86625279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs147159650 | chr13:86625280-86625281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs185232460 | chr13:86625295-86625296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568057510 | chr13:86625328-86625329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533743188 | chr13:86625380-86625381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75665275 | chr13:86625416-86625417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35377825 | chr13:86625433-86625434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs576848425 | chr13:86625437-86625438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539332498 | chr13:86625449-86625450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74814729 | chr13:86625479-86625480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544261291 | chr13:86625480-86625481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562261566 | chr13:86625489-86625490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs207474156 | chr13:86625506-86625507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539730022 | chr13:86625508-86625509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114563800 | chr13:86625514-86625515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569862695 | chr13:86625588-86625589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188801179 | chr13:86625589-86625590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555541527 | chr13:86625636-86625637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192640211 | chr13:86625652-86625653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12873140 | chr13:86625678-86625679 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs541040184 | chr13:86625683-86625684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185079673 | chr13:86625696-86625697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577955881 | chr13:86625713-86625714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545291656 | chr13:86625745-86625746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs138727426 | chr13:86625758-86625759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs111261304 | chr13:86625791-86625792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149342726 | chr13:86625825-86625826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144625390 | chr13:86625878-86625879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561600166 | chr13:86625880-86625881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371869037 | chr13:86625930-86625931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547449575 | chr13:86626029-86626030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113608170 | chr13:86626037-86626038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs533311931 | chr13:86626058-86626059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141143694 | chr13:86626062-86626063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551655340 | chr13:86626068-86626069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569844620 | chr13:86626111-86626112 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77480080 | chr13:86626125-86626126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs549480577 | chr13:86626147-86626148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567685060 | chr13:86626191-86626192 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:86624800-86625600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr13:86625200-86625600 | Enhancers | A549 | lung |
3 | chr13:86625200-86625800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr13:86625400-86626200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr13:86625600-86626200 | Enhancers | Hela-S3 | cervix |
6 | chr13:86626200-86627800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr13:86627200-86627600 | Active TSS | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |